683 Capital Management, LLC
CIK: 0001404574Latest portfolio: $2.3B · Q4 2025
Holdings
225
Total Value
$2.3B
New Positions
110
Closed Positions
19
Top Holdings
View All 225 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | PLTRPALANTIR TECHNOLOGIES INC | 2,328,700 | $413.9M | 18.01% | +1.2M | Put |
| 2 | LLYELI LILLY & CO | 154,000 | $165.5M | 7.20% | -18,750 | Put |
| 3 | COFCAPITAL ONE FINL CORP | 410,000 | $99.4M | 4.32% | +10K | Put |
| 4 | TSLATESLA INC | 210,000 | $94.4M | 4.11% | -500 | Put |
| 5 | NVDANVIDIA CORPORATION | 456,000 | $85.0M | 3.70% | NEW | Put |
| 6 | WVEWAVE LIFE SCIENCES LTD | 4,015,000 | $68.3M | 2.97% | -135,000 | |
| 7 | CVNACARVANA CO | 150,000 | $63.3M | 2.75% | — | |
| 8 | MDGLMADRIGAL PHARMACEUTICALS INC | 99,000 | $57.7M | 2.51% | -53,000 | Put |
| 9 | ALNYALNYLAM PHARMACEUTICALS INC | 144,882 | $57.6M | 2.51% | +9K | Put |
| 10 | PRAXPRAXIS PRECISION MEDICINES I | 169,800 | $50.0M | 2.18% | NEW | Put |
| 11 | BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | 21,750,000 | $41.1M | 1.79% | — | |
| 12 | PTGXPROTAGONIST THERAPEUTICS INC | 430,969 | $37.6M | 1.64% | NEW | Call |
| 13 | GXOGXO LOGISTICS INCORPORATED | 685,000 | $36.1M | 1.57% | -90,000 | |
| 14 | HGVHILTON GRAND VACATIONS INC | 745,000 | $33.3M | 1.45% | +120K | |
| 15 | ANABANAPTYSBIO INC | 648,093 | $31.4M | 1.37% | +101K | |
| 16 | UWMCUWM HOLDINGS CORPORATION | 7,050,518 | $30.9M | 1.34% | -349,482 | |
| 17 | PHATPHATHOM PHARMACEUTICALS INC | 1,785,000 | $29.6M | 1.29% | -35,380 | |
| 18 | QUREUNIQURE NV | 1,135,050 | $27.2M | 1.18% | NEW | Call |
| 19 | WDCWESTERN DIGITAL CORP | 143,300 | $24.7M | 1.07% | -195,700 | |
| 20 | IONQIONQ INC | 544,200 | $24.4M | 1.06% | +339K | Put |
| 21 | AMTMAMENTUM HOLDINGS INC | 835,000 | $24.2M | 1.05% | -440,000 | |
| 22 | MOHMOLINA HEALTHCARE INC | 135,000 | $23.4M | 1.02% | +54K | |
| 23 | KSPIKASPI KZ JSC | 265,000 | $20.7M | 0.90% | NEW | |
| 24 | MGTXMEIRAGTX HLDGS PLC | 2,559,082 | $20.3M | 0.89% | -65,918 | |
| 25 | AMLXAMYLYX PHARMACEUTICALS INC | 1,650,000 | $19.9M | 0.87% | -110,000 |
Quarterly Changes
New Positions
Increased Positions
Sector Breakdown
HealthcareNaN% ($InfinityT)
Technology0.0% ($4.139268504424687e+75T)
Consumer Cyclical0.0% ($9.444163303333382e+70T)
Unknown0.0% ($4.106816972129361e+64T)
Financial Services0.0% ($9.936730881154226e+56T)
Industrials0.0% ($3.6058242151511145e+52T)
Energy0.0% ($1.1580692068113222e+26T)
Basic Materials0.0% ($1.7420145987925567e+24T)
Real Estate0.0% ($640530311038573440.0T)
Communication Services0.0% ($112687141405.8T)
Consumer Defensive0.0% ($148.4T)
Filing History
| Quarter | Filing Date | Portfolio Value | Holdings |
|---|---|---|---|
| Q4 2025 | Feb 17, 2026 | $2.3B | 234 |
| Q3 2025 | Nov 14, 2025 | $1.9T | 139 |
| Q2 2025 | Aug 14, 2025 | $1.5T | 134 |
| Q1 2025 | May 15, 2025 | $1.4T | 140 |
| Q4 2024 | Feb 14, 2025 | $1.6T | 225 |
| Q3 2024 | Nov 14, 2024 | $1314.9T | 143 |
| Q2 2024 | Aug 14, 2024 | $1323.2T | 145 |
| Q1 2024 | May 15, 2024 | $1366.6T | 135 |
| Q4 2023 | Feb 14, 2024 | $1221.0T | 259 |
| Q3 2023 | Nov 14, 2023 | $1286.3T | 157 |
| Q2 2023 | Aug 14, 2023 | $1392.3T | 167 |
| Q1 2023 | May 15, 2023 | $1342.6T | 298 |
| Q4 2022 | Feb 14, 2023 | $1181.5T | 308 |
| Q3 2022 | Nov 14, 2022 | $1.3T | 245 |
| Q2 2022 | Aug 15, 2022 | $1.4T | 271 |
| Q1 2022 | May 16, 2022 | $1.9T | 358 |
| Q4 2021 | Feb 14, 2022 | $2.7T | 350 |
| Q3 2021 | Nov 15, 2021 | $2.6T | 219 |
| Q2 2021 | Aug 16, 2021 | $2.9T | 199 |
| Q1 2021 | May 17, 2021 | $1.9T | 167 |
| Q4 2020 | Feb 16, 2021 | $2.1T | 209 |
| Q3 2020 | Nov 16, 2020 | $1.4T | 144 |
| Q2 2020 | Aug 14, 2020 | $1.2T | 145 |
| Q1 2020 | May 15, 2020 | $846.6B | 147 |
| Q4 2019 | Feb 14, 2020 | $874.3B | 168 |
| Q3 2019 | Nov 14, 2019 | $899.3B | 151 |
| Q2 2019 | Aug 14, 2019 | $1.1T | 173 |
| Q1 2019 | May 15, 2019 | $1.1T | 169 |
| Q4 2018 | Feb 14, 2019 | $1.6T | 190 |
| Q3 2018 | Nov 14, 2018 | $1.5T | 162 |
| Q2 2018 | Aug 14, 2018 | $1.5T | 149 |
| Q1 2018 | May 15, 2018 | $1.1T | 144 |
| Q4 2017 | Feb 14, 2018 | $1.2T | 152 |
| Q3 2017 | Nov 14, 2017 | $951.6B | 123 |
| Q2 2017 | Aug 14, 2017 | $678.8B | 99 |
| Q1 2017 | May 15, 2017 | $643.6B | 86 |
| Q4 2016 | Feb 14, 2017 | $1.4T | 107 |
| Q3 2016 | Nov 14, 2016 | $941.7B | 96 |
| Q2 2016 | Aug 15, 2016 | $627.2B | 73 |
| Q1 2016 | May 16, 2016 | $560.8B | 68 |
Fund Information
683 Capital Management, LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $2.3B across 225 holdings. The largest position is PALANTIR TECHNOLOGIES INC (PLTR), representing 18.0% of the portfolio. Compared to the previous quarter, the fund opened 115 new positions and closed 23 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.